Covid Flu A/B and RSV 4 in 1 Diagnostic Test
NCT07308158 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1119
Last updated 2026-01-08
Summary
The goal of this observational study is to evaluate the diagnostic performance of an investigational Flu A/B, COVID-19 and RSV test in patients with signs and symptoms of respiratory infection.
The main questions it aims to answer are:
1. What is the sensitivity and specificity of the investigational test compared with an FDA-cleared reference method for detection of Influenza A, Influenza B, , SARS-CoV-2 and respiratory syncytial virus antigen.
2. What is the overall positive and negative percent agreement between the investigational test and the reference method?
Participants will:
1. Provide a respiratory specimen (e.g., nasal or nasopharyngeal swab) for testing with the investigational device.
2. Provide an additional specimen for testing with the FDA-cleared reference method.
Conditions
- Influenza A
- Influenza B
- COVID - 19
- RSV
Interventions
- DIAGNOSTIC_TEST
-
Investigational Flu A/B Covid-19 and RSV Diagnostic Test
A diagnostic test in lateral flow cassette format designed to detect Influenza A, Influenza B, SARS-CoV-2 and respiratory syncytial virus from anterior nasal swab specimens.
Sponsors & Collaborators
-
iHealth Labs inc
lead INDUSTRY
Eligibility
- Min Age
- 6 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-11-15
- Primary Completion
- 2025-12-12
- Completion
- 2025-12-12
- FDA Device
- Yes
Countries
- United States
- Puerto Rico
Study Locations
More Related Trials
-
Efficacy and Safety of Nasal Spray Solution Containing Human IgG1 Anti-COVID-19 Antibody Cocktail
NCT05358873 ·Status: COMPLETED ·Phase: NA
-
Study of the Safety, Tolerability and Immunogenicity of an Intranasal Influenza Vaccine Administered to Healthy Adults
NCT03293732 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1045 (Influenza and Respiratory Syncytial Virus [RSV]) or mRNA-1230 (Influenza, RSV, and Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2]) Vaccine in Adults 50 to 75 Years Old
NCT05585632 ·Status: COMPLETED ·Phase: PHASE1
-
FLU A+B Nasal Swab Clinical Study
NCT00636662 ·Status: COMPLETED
-
Proteomic Profiling for Influenza Vaccination - FluMist
NCT00385281 ·Status: COMPLETED ·Phase: PHASE4
-
Validation of the Ellume® Respirio Flu Test and the Ellume® eLab Flu Test for the Rapid Identification of Influenza A/B
NCT02767414 ·Status: COMPLETED ·Phase: NA
-
Influenza Diagnosis, Treatment and Surveillance With Xpert Flu
NCT01947049 ·Status: COMPLETED ·Phase: NA
-
A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People
NCT06683352 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients
NCT02087761 ·Status: UNKNOWN
-
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
NCT01309568 ·Status: COMPLETED
-
Ellume.Lab Flu A+B Test and iTreat Flu A+B Flu Test Performance Versus Viral Culture and Reverse Transcriptase Polymerase Chain Reaction.
NCT03248960 ·Status: COMPLETED ·Phase: NA
-
A Study To Learn About The Study Vaccine (Called Self-Amplifying Ribonucleic Acid (RNA)) For The Prevention of Influenza
NCT05227001 ·Status: COMPLETED ·Phase: PHASE1
-
Rechallenge With a Low Pathogenicity Avian H10N7 Influenza Virus in Healthy Human Volunteers Previously Challenged With H10N7 Influenza
NCT07215871 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
Dose, Safety, and Pathogenicity of a New Influenza A H3N2 Challenge Strain
NCT06613737 ·Status: COMPLETED ·Phase: NA
-
Clinical Performance Study of the Ultra Influenza A&B Test Using Nasal Swabs for Identifying Subjects Who Are Infected With the Influenza Virus Strain Type A or Type B
NCT01753531 ·Status: COMPLETED
-
Mucosal and Systemic Immunity After Viral Challenge of Healthy Volunteers Vaccinated With Inactivated Influenza Vaccine Via the Intranasal Versus Intramuscular Route
NCT03845231 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1 Candidate Seasonal Influenza Vaccines in Healthy Adults
NCT05827068 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Clinical Performance of the Diassess Influenza A and B Test
NCT03035396 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5407 in Adult Participants18 Years of Age and Older
NCT05553301 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 (Influenza and COVID-19) Vaccine in Adults ≥18 to <65 Years of Age
NCT06864143 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity Study of Adenovirus-vectored, Intranasal Pandemic Influenza Vaccine.
NCT00755703 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity First-in-human Dose-ranging Study of Self-Amplifying RNA Seasonal Influenza Vaccine in Adults
NCT06125691 ·Status: COMPLETED ·Phase: PHASE1
-
Prospective Evaluation of the Fluid Rapid Influenza Test
NCT00826709 ·Status: SUSPENDED ·Phase: PHASE3
-
Efficacy of FLU-v in an H1N1 Influenza Human Challenge Model
NCT03180801 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of mRNA-1020 and mRNA-1030 Seasonal Influenza Vaccines in Healthy Adults
NCT05333289 ·Status: COMPLETED ·Phase: PHASE1/PHASE2